Andromachi Giannopoulou

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

Amgen (Switzerland)(Current)

Amgen (United States)

Andromachi Giannopoulou is an author at Amgen (Switzerland) specializing in pharmacoeconomic modeling, cost-effectiveness analysis, and cost-effectiveness modeling.

Publications per year

2016–2023

Publications

Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective

Andrzej Jakubowiak, Marco Campioni, Ágnes Benedict et al. · Journal of Medical Economics · 2016 · 51 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers

D. Gwyn Bebb, Cressida Murray, Andromachi Giannopoulou et al. · Pulmonary Therapy · 2023 · 10 citations · Full text

Medicine, Oncology, Cancer Symptom Management +16

1–2 of 2